AXSM filings
Corporate insider profile
Mark Coleman Filing Activity
Latest reported as Director of Axsome Therapeutics, Inc. (AXSM).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$4,179,576.88
- Latest transaction
- Jun 10, 2026
Affiliated corporations
Reported company relationships
Transaction history
